Discover 1,527 paid clinical trials in Boulder, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,527
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for
Chronic Spontaneous Urticaria (CSU)
Location: Aurora CO, Colorado Springs CO, Sandy City UT,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06868212
Phase3, Recruiting
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
for
Pancreatic Cancers, Pancreatic Diseases
Location: Aurora CO, Cleveland OH
Sponsor: Do Hyun Park
Sex: All
Age: 19+
Code: NCT07030348
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Aurora CO, Topeka KS, Oklahoma City OK, Kansas City MO,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07018323
Phase2, Recruiting
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
for
Lung Cancer, Lung Metastases
Location: Aurora CO, Rochester MN, Duarte CA, Houston TX,
Sponsor: Vergent Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07499674
Phase3, Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
for
Respiratory Insufficiency,
Location: Aurora CO, Farmington UT, Omaha NE, Tucson AZ, Winnipeg,
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05440851
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors
for
Unhealthy Alcohol Use, Alcohol Use Disorders
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: Male
Age: 18 - 70+
Code: NCT02465177
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Location: Aurora CO, Salt Lake City UT, Omaha NE, Bellevue NE,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sex: All
Age: 18+
Code: NCT04031677
Phase3, Recruiting
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
for
Acute Kidney Injury, Hemolysis, Thrombocytopenia, Surgery
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT06349577
Recruiting
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
for
Metastatic Dedifferentiated Liposarcoma,
Location: Aurora CO, St Louis MO, Los Angeles CA, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05711615
Phase1, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Aurora CO, Loveland CO, Greeley CO, Fort Collins CO,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
for
Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Aurora CO, Irvine CA, Madison WI, Chicago IL,
Sponsor: University of Colorado, Denver
Sex: Female
Age: 18 - 70+
Code: NCT05887609
Phase2, Recruiting
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Aurora CO, Saint Paul MN, San Diego CA, Houston TX,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: Male
Age: 2 - 65
Code: NCT06430385
Phase1, Phase2, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer